Current landscape of clinical trials for vitiligo: improving outcome standardization and trial diversity.

We assessed interventional clinical trials for vitiligo from 2015 to 2021 noting patient demographics, intervention types and reported outcomes. We discuss that across studies, more consistent documentation of patient characteristics as well as more variable intervention types may broaden trial generalizability and provide benefit to more patients.